Scholarlink

<p>The MAPK/ERK pathway coordinates multiple cellular functions, including proliferation, apoptosis, and motility, yet it is frequently modeled as a one-purpose cascade. Pathway complexity stems from the existence of isoforms that are regulated differently and have specific interacting partners. Here, we overcome combinatorial complexity by constructing a rule-based model of the MAPK/ERK pathway that accounts for differential regulation of MEK and RAF isoforms and RAF interactions with 14-3-3 proteins. The model addresses signaling based on the enzymatic cascade as well as regulatory protein-protein interactions. We propose that at low concentrations of growth factors, RAS is activated only in a portion of the membrane. This allows the model to reconcile the observed graded and switch-like responses observed at the upper (RAS and RAF) and the lowest (ERK) tiers of the pathway, respectively. We demonstrate that functional differences between BRAF and CRAF, or ARAF, can arise from their distinct interactions with 14-3-3. The 14-3-3 dimers inhibit all RAF monomers in the closed form and preferentially stabilize BRAF-CRAF or BRAF-ARAF dimers and may not stabilize RAF dimers without BRAF. The constructed model is used to explore qualitative differences in MAPK/ERK pathway signaling across different cell lines. The exploration starts from the nominal model parameters chosen to reflect a generic cell.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A computational rule-based model of MAPK/ERK system regulation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月21日

查看全文
  • Paweł Kocieniewski,
  • Tomasz Lipniacki

摘要

The MAPK/ERK pathway coordinates multiple cellular functions, including proliferation, apoptosis, and motility, yet it is frequently modeled as a one-purpose cascade. Pathway complexity stems from the existence of isoforms that are regulated differently and have specific interacting partners. Here, we overcome combinatorial complexity by constructing a rule-based model of the MAPK/ERK pathway that accounts for differential regulation of MEK and RAF isoforms and RAF interactions with 14-3-3 proteins. The model addresses signaling based on the enzymatic cascade as well as regulatory protein-protein interactions. We propose that at low concentrations of growth factors, RAS is activated only in a portion of the membrane. This allows the model to reconcile the observed graded and switch-like responses observed at the upper (RAS and RAF) and the lowest (ERK) tiers of the pathway, respectively. We demonstrate that functional differences between BRAF and CRAF, or ARAF, can arise from their distinct interactions with 14-3-3. The 14-3-3 dimers inhibit all RAF monomers in the closed form and preferentially stabilize BRAF-CRAF or BRAF-ARAF dimers and may not stabilize RAF dimers without BRAF. The constructed model is used to explore qualitative differences in MAPK/ERK pathway signaling across different cell lines. The exploration starts from the nominal model parameters chosen to reflect a generic cell.